CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
3.720
+0.010 (0.27%)
Jan 31, 2025, 4:00 PM EST - Market closed
CollPlant Biotechnologies Employees
CollPlant Biotechnologies had 75 employees as of December 31, 2023. The number of employees increased by 2 or 2.74% compared to the previous year.
Employees
75
Change (1Y)
2
Growth (1Y)
2.74%
Revenue / Employee
$8,667
Profits / Employee
-$232,267
Market Cap
42.61M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
CLGN News
- 2 months ago - CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 2 months ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - PRNewsWire
- 5 months ago - CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 5 months ago - CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants - Business Wire
- 6 months ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION - PRNewsWire
- 6 months ago - CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report - PRNewsWire